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Abstract
Autoantibodies that target the water channel aquaporin-4 (AQP4) in neuromyelitis optica (NMO) are IgG1, a T cell-
dependent Ig subclass. However, a role for AQP4-specific T cells in this CNS inflammatory disease is not known. To evaluate
their potential role in CNS autoimmunity, we have identified and characterized T cells that respond to AQP4 in C57BL/6 and
SJL/J mice, two strains that are commonly studied in models of CNS inflammatory diseases. Mice were immunized with
either overlapping peptides or intact hAQP4 protein encompassing the entire 323 amino acid sequence. T cell determinants
identified from examination of the AQP4 peptide (p) library were located within AQP4 p21-40, p91-110, p101-120, p166-180,
p231-250 and p261-280 in C57BL/6 mice, and within p11-30, p21-40, p101-120, p126-140 and p261-280 in SJL/J mice. AQP4-
specific T cells were CD4
+ and MHC II-restricted. In recall responses to immunization with intact AQP4, T cells responded
primarily to p21-40, indicating this region contains the immunodominant T cell epitope(s) for both strains. AQP4 p21-40-
primed T cells secreted both IFN-c and IL-17. The core immunodominant AQP4 21-40 T cell determinant was mapped to
residues 24-35 in C57BL/6 mice and 23-35 in SJL/J mice. Our identification of the AQP4 T cell determinants and
characterization of its immunodominant determinant should permit investigators to evaluate the role of AQP4-specific T
cells in vivo and to develop AQP4-targeted murine NMO models.
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Introduction
Neuromyelitis optica (NMO) is a rare, aggressive, often fatal,
inflammatory demyelinating disease that predominantly affects the
optic nerves and spinal cord [1,2,3]. For many years, NMO was
considered a subtype of multiple sclerosis (MS). However, it is now
recognized that a majority of NMO patients develop autoanti-
bodies (NMO-IgG) against aquaporin 4 (AQP4) [4]. AQP4 is the
predominant water channel in the central nervous system and is
localized in astrocyte foot processes, but can also be found in other
organs, including kidneys, heart and lungs. Therefore, restricted
inflammation of NMO cannot be solely explained by the pattern
of expression of AQP4. AQP4-specific antibodies in NMO
patients are IgG1 [5], an antibody subclass that requires help
from antigen (Ag)-specific CD4
+ T cells [6,7]. Although little is
known regarding recognition of AQP4 by T cells, AQP4-specific T
cells may drive the humoral AQP4-specific immune response.
While AQP4 is the most characterized candidate autoantigen in
NMO, it is not known whether an immune response that
selectively targets AQP4 initiates the pathologic changes associated
with NMO. Development of animal models for NMO should
permit direct assessment of immune responses in vivo. A "Devic-
like" disease, characterized by spontaneous optic neuritis and
paralysis associated with spinal cord inflammation occurred when
myelin oligodendrocyte glycoprotein (MOG)-specific T cell
receptor (TCR) transgenic (Tg) mice were crossed to MOG-
specific B cell receptor (BCR) knock-in mice [8,9]. However, the
autoantigen was MOG, and not AQP4. Models that target AQP4
have met with modest success [10,11,12]. For example, it was
observed that AQP4-specific antibodies promoted NMO-like
pathologic changes within the CNS of rats with experimental
autoimmune encephalomyelitis (EAE), a myelin-specific T-cell
mediated CNS inflammatory disease. However, these pathologic
changes did not occur in the absence of T-cell mediated
inflammation, suggesting that T cells may have an important role
in NMO pathogenesis.
Our goal in this investigation was to characterize T cell
recognition of AQP4. In this regard, we have examined AQP4 T
cell reactivity in C57BL/6 (H-2
b) and SJL/J (H-2
s) mice, two
strains that are susceptible to various models of autoimmune
neurologic disease [13,14,15], including the CNS demyelinating
disease EAE [13]. We evaluated T cell reactivity by immunizing
mice with individual overlapping 15 and 20 amino peptides from a
library encompassing the entire AQP4 sequence, and tested recall
to these peptides. To characterize the naturally processed AQP4
determinants, we have immunized mice with intact AQP4 and
tested recall to AQP4 peptides. Here, we report on the
identification of several discrete AQP4 T cell determinants and
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e15050the characterization of the naturally processed immunodominant
determinants.
Results and Discussion
Identification of AQP4 T cell determinants
In contrast to B cells and their secreted antibodies, which
frequently recognize conformational determinants, Ag-specific
CD4
+ T cells recognize specific Ag determinants in association
with MHC II molecules expressed on the cell surface of Ag
presenting cells (APCs) [16]. We first identified the immunogenic
regions of AQP4 by testing proliferative T cell responses to
individual peptides from a library of overlapping 15-mers and 20-
mers encompassing the entire AQP4 sequence. By direct
immunization of C57BL/6 mice with murine AQP4 peptides,
we identified five regions of AQP4 that contain T cell
determinants: p21-40, p91-110, p101-120, p161-180, p231-250
and p261-280 (Figure 1A). Of these peptides, proliferative
responses to p21-40, p91-110, p161-180 and p261-280 were more
robust. AQP4 T cell determinants in SJL/J were located within
p11-30, p21-40, p101-120, 126-140 and p261-280 (Figure 1B). T
cells that proliferated to AQP4 were CD4
+ and MHC II-restricted
(data not shown). All AQP4 T cell determinants in C57BL/6 and
SJL/J mice were found within putative transmembrane or
cytoplasmic domains (Figure 2). Specifically, we did not identify
T cell determinants within the three extracellular domains, the A,
C, and E loops [17], which may contain B cell determinants
recognized by AQP4-specific antibodies from NMO patients [18].
AQP4 p21-40 is the naturally processed
immunodominant determinant for recognition by CD4
+
T cells
Although peptide fragments can bind cell surface MHC
molecules directly and elicit T cell immune responses, presentation
of native Ag by APCs to CD4
+ T cells in vivo usually requires
processing, which involves proteolytic degradation of protein
within APCs and association of peptide cleavage products with
MHC II molecules [19,20]. Thus, in parallel with our analysis by
direct immunization of AQP4 peptides, C57BL/6 and SJL/J mice
Figure 1. Identification of AQP4 peptides that elicit T cell responses. AQP4 peptides were tested for their capability to induce T cell
proliferative responses in (A) C57BL/6 and (B) SJL/J mice. Each overlapping 20-mer AQP4 peptide is indicated by first residue. Mice were immunized
subcutaneously with 100 mg murine AQP4 20-mer peptides in CFA. 10–12 days later, lymph node cells were isolated and tested in vitro for recall
responses to the mouse or corresponding human peptides used for immunization. Data are shown as stimulation indices (SI’s) of mean proliferative
responses in the presence of peptide (25 mg/ml) compared to the absence of antigen (background). Standard errors (+/2 SEM) are shown for
proliferative responses tested in triplicate.
doi:10.1371/journal.pone.0015050.g001
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to intact AQP4 and the individual overlapping AQP4 peptides.
Using this approach, we could identify the naturally processed
immunodominant AQP4 determinants. Intact human AQP4,
which is 93% homologous to mouse AQP4 [17] (Figure 2), was
used as the immunogen. Immunization with recombinant human
AQP4 elicited significant proliferation to itself in both strains
(Figure 3), although the magnitude was lower in comparison to the
stimulation induced by the most immunogenic AQP4 peptides
(Figure 1). For the negative controls, no response was found to
either MOG 35-55 (C57BL/6) or PLP 139-151 (SJL/J) after
AQP4 immunization (data not shown). In both strains, a
significant recall response was detected to mouse AQP4 p21-40
(Figure 3 and 4A), indicating that this is a naturally processed
determinant of intact AQP4. T cells that recognized AQP4 p21-40
secreted IFN-c and IL-17, indicating that both Th1 and Th17
immune responses were elicited (Figure 4B). Our findings also
suggest that peptides p91-110, p101-120, p166-180, p231-250 and
p261-280, which elicited responses in C57BL/6 mice (Figure 1),
and p11-30, p101-120, p126-140 and p261-280, which elicited
responses in SJL/J mice, were not efficiently processed (Figure 3).
To further examine this possibility, we generated T cell lines to
these AQP4 peptides. In contrast to AQP4 p21-40-specific T cells,
other AQP4 peptide-specific T cell lines proliferated in response to
their respective AQP4 determinants, but less efficiently, or not at
all, to intact AQP4 (Figure 4C). Collectively, our results indicate
that AQP4 p21-40 contains a naturally processed immunodomi-
nant AQP4 determinant.
Figure 2. Localization of identified murine AQP4 T cell epitopes. AQP4 peptides that elicited proliferative responses in (A) C57BL/6 and (B)
SJL/J mice are located within putative transmembrane and cytoplasmic domains. (C) Sequences of human (hAQP4) [34] and murine [17] AQP4
(mAQP4). Dashes represent homologous regions between the two species.
doi:10.1371/journal.pone.0015050.g002
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AQP4 p21-40
In general, MHC II-restricted CD4
+ T cells recognize 9-13
amino acid peptides [16,20]. In order to further characterize the
immunodominant AQP4 T cell epitope(s), synthetic truncated
peptides corresponding to sequences within AQP4 21-40 were
synthesized and tested for recognition by p21-40-specific T cells.
AQP4 p21-40-specific T cells from C57BL/6 mice proliferated in
response to p21-35, p23-35 and p24-35, but not to p26-40
(Figure 5A and B). Shorter AQP4 peptides, p25-35 and p23-34
also stimulated proliferation of p21-40-specific T cells, although
less efficiently. These results indicate that p24-35 is the core
immunodominant AQP4 T cell determinant in C57BL/6 mice.
AQP4 p21-40-specific T cells from SJL/J mice also recognized
p21-35, but neither p25-38 (Figure 5C and D), nor p26-40 (data
not shown). Those T cells responded nearly as efficiently to AQP4
p23-35 as to p21-35, but did not respond to p24-35 or p25-35,
demonstrating that the immunodominant AQP4 T cell determi-
nant in SJL/J mice is p23-35. Thus, our data suggest that the
immunodominant T cell epitopes for C57BL/6 and SJL/J mice
are located in the same 13 amino acid sequence, p23-35, although
the fine specificities are not identical.
It is notable that the amino acid residues with the immunodo-
minant determinant are important in AQP4 functions [21,22].
Residues 24-26 are critical for the assembly of orthogonal arrays of
particles (OAPs), which are thought to enhance water transport
[21]. AQP4 residues 23-32 also contain the site required for the
interaction with the regulator glutamate receptor 5 (mGluR5) and
the catalytic subunit of Na,K-ATPase in forming macromolecular
microdomains that may participate in K
+ homeostasis [22].
Although intriguing, T cell recognition of this same region of
AQP4 is probably coincidental, since determinants recognized by
CD4
+ T cells are generally created through processing and
association with MHC II molecules [16]. Further, unlike profes-
sional APCs, including microglia and dendritic cells, astrocytes,
which express AQP4, are not efficient APCs in vivo [23].
While mouse and human AQP4 are 93% homologous, it is
recognized that small differences in amino acid sequences, e.g.
Figure 3. Identification of naturally processed AQP4 determinants. AQP4 peptides were tested for their ability to induce T cell proliferative
responses in intact hAQP4-primed (A) C57BL/6 and (B) SJL/J mice. Each 20-mer AQP4 peptide is indicated by first residue. Mice were immunized
subcutaneously with 100 mg recombinant intact hAQP4 in CFA. 10–12 days later, lymph node cells were cultured in vitro for recall responses to the
indicated human or mouse overlapping 20-mer peptides. Data are shown as stimulation indices (SI’s) of mean proliferative responses in the presence
of peptide (25 mg/ml) compared to the absence of antigen (background). Standard errors (+/2 SEM) are shown for proliferative responses tested in
triplicate. Recall to intact hAQP4 is shown for comparison.
doi:10.1371/journal.pone.0015050.g003
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PLoS ONE | www.plosone.org 4 November 2010 | Volume 5 | Issue 11 | e15050Figure 4. AQP4 p21-40 is a naturally processed immunodominant determinant of intact AQP4. (A) C57BL/6 (above) and SJL/J (below)
mice were immunized subcutaneously with 100 mg recombinant intact hAQP4 in CFA. Lymph nodes were harvested at day 10–12 and cultured in the
presence of various concentrations of either intact hAQP4 (left), or individual murine AQP4 peptides (right) for 4 days. Proliferation was measured by
3H-thymidine incorporation, and are presented as mean cpm +/2 SEM for triplicates. (B) C57BL/6 (above) and SJL/J (below) m21-40 primed lymph
node cells were assayed for cytokine production and proliferation in response to m21-40 peptide. Supernatants were collected after 72 hr for IFN-c
and IL-17A for ELISA. Data are presented as mean +/2 SEM for triplicates. (C) Proliferation of C57BL/6 T cell lines specific to p21-40, p91-110, p166-
180, and p261-280 were assayed following re-stimulation with various concentrations of intact hAQP4 (left) and self-peptides (right). Data are shown
as stimulation indices (SI’s) of triplicates of antigen proliferation over no antigen conditions (background).
doi:10.1371/journal.pone.0015050.g004
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important effects on MHC binding as well as TCR-mediated
stimulation [24,25]. However, three of the immunogenic AQP4
peptides that we identified, p91-110 and p166-180 in C57BL/6
mice (Figure 1A), and p126-140 in SJL/J mice (Figure 1B), share
identical sequences between mouse and human AQP4 (Figure 2C).
Further, we observed cross-reactivity for most immunogenic
AQP4 peptides that were not entirely homologous. Mouse
AQP4 p21-40, which has xenogenic substitutions at residues 21
and 39, stimulated T cell responses to both itself and human
AQP4 p21-40, and mouse p21-40-specific T cell lines were also
stimulated by human intact AQP4 (Figure 4C). Our findings
clearly indicate that AQP4 21-40 is an immunodominant region of
AQP4 in both strains.
In this investigation, we have identified immunogenic T cell
determinants using a library of overlapping peptides encompassing
the entire sequence of AQP4. While this approach may be
considered labor-intensive, several different in silico methods have
recently been developed in order to efficiently identify potential
MHC-restricted T cell determinants [26,27,28,29]. Many of these
programs base predictions upon existing quantitative peptide
binding affinities for specific MHC molecules [26,27,28,29]. In
general, methods for predicting MHC I-restricted determinants
have advanced more rapidly, in part due to the fact that MHC II
has an open binding groove accommodating larger peptides. For
most programs available, there is better poor resolution for I-A
b
(Figure 6A) than for I-A
s (Figure 6B), possibly reflecting the larger
database of known I-A
b-restricted T cell determinants of Ag.
MetaSVMp, a program that utilizes relative affinities of identified
determinants from the immune epitope database (IEDB) to predict
MHC II binding peptides [26,27,30], identified eight distinct
regions of AQP4 that contain potential determinants that bind I-
A
b for T cell recognition (Figure 6A top panel). AQP4 p21-40
ranked among the top 12 percentile of predicted I-A
b-binding
AQP4 15-mers (Figure 6A bottom panel). However, MetaSVMp
did not predict T cell recognition of AQP4 166-180 or 261-280.
MetaSVMp also predicted the AQP4 sequence 121-140 within the
top one percentile, yet we did not detect proliferation to this
peptide either by recall to direct peptide immunization or in
response to intact AQP4 in C57BL/6 mice. Therefore, our results
caution against relying solely upon using predictive algorithms for
identification of T cell epitopes of proteins.
The presence of T cells within active NMO lesions [2], evidence
for clonal T cell expansion in peripheral blood of NMO patients
[31], and the observations that AQP4-specific antibodies from
NMO patients were not pathogenic in rats in the absence of CNS
inflammation provide indirect evidence suggesting that T cells may
participate in the etiology of NMO. Knowing that AQP4-specific
antibodies in NMO serum are T-cell dependent IgG (IgG1) points
to antigen-specific CD4
+ T cell-mediation of its humoral response.
However, there are several questions regarding the location and
nature of AQP4-specific T cells in NMO pathogenesis. Do AQP4-
specific T cells direct the AQP4-specific immune response outside
the CNS? Do AQP4-specific T cells participate directly in CNS
inflammation? Serum NMO IgG concentrations are higher than
CSF levels [32], indicating that development of AQP4-specific
Figure 5. Characterization of the minimal core T cell epitope within AQP4 p21-40. AQP4 p21-40-specific T cells were restimulated with
truncated peptides to determine the core of the p21-40 determinant in (A, B) p21-40 specific C57BL/6 cell lines and (C, D) p21-40 specific SJL/J
primary lymph node cells. Cell lines were restimulated with irradiated syngeneic splenic APC and various concentrations of p21-40 or truncated
peptides. After 48 hours (cell lines) or 72 hours (LN), cultures were pulsed with
3H-thymidine and harvested 16 hours later. Data shown represent
means of triplicates +/2 SEM.
doi:10.1371/journal.pone.0015050.g005
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b- and I-A
s- binding mAQP4 epitopes for T cell recognition. MetaSVMp, a quantitative binding affinity program that
employs the immune epitope database (IEDB) [26,27,30], was used to identify potential I-A
b- and I-A
s-binding of AQP4 determinants for T cell
recognition. Inverse of 50% inhibition concentration values (1/IC50) is plotted for I-A
b (A top panel) and I-A
s (B top panel). Peaks correspond to
increased predicted binding affinity: strong binding, IC50,500 nM; moderate binding, IC50.500 nM and ,5,000 nM, and non-binding,
IC50.5,000 nM. Peaks correspond to increased predicted binding affinity. The top 20% of all possible epitopes are shown for I-A
b (A bottom
panel) and I-A
s (B bottom panel). MetaSVMp percentile ranks were acquired from the MetaMHC web-based application; tall peaks correspond to top-
ranked predicted epitopes.
doi:10.1371/journal.pone.0015050.g006
T Cell Epitopes of Aquaporin-4, AQP4
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e15050antibodies occurs outside the CNS and is driven by stimulation
within the peripheral immune compartment. Observations that
encephalitogenic MBP-specific T cells promoted the development
of NMO-like lesions upon transfer of AQP4-specific antibodies
provided evidence that inflammation initiated by a T cell immune
response to a CNS myelin antigen was sufficient for entry of AQP4-
specific antibodies, and questions whether the cellular response that
initiates CNS inflammation in NMO must necessarily target AQP4.
Elevated levels of IFN-c and IL-17 have also been detected within
the CSF of NMO patients [33], supporting the existence of both Th1
and Th17 responses. Active NMO lesions are characterized by the
abundance of eosinophilsand neutrophils [2],which suggests that Th2
and Th17 cells may have a key role in the CNS inflammation. While it
may not be feasible in clinical studies to assess whether AQP4-specific
T cells participate directly in NMO pathogenesis, now that we have
discovered the T cell determinants of AQP4, it should permit
investigators to determine the relative contribution of these subsets of
AQP4-specific T cells in the initiation of CNS inflammatory responses
in models. Efforts in developing a murine AQP4-based NMO model
should focus on the AQP4 T cell epitopes identified, and in particular
to the N-terminal region. The identification of regions of AQP4
recognized in mice may also provide insights regarding recognition of
human AQP4 by NMO patients.
Materials and Methods
Mice
C57BL/6 (H-2
b) and SJL/J (H-2
s) female mice, 8 weeks of age,
were purchased from the Jackson Laboratories (Bar Harbor, ME)
and housed under specific pathogen-free conditions at UCSF
Laboratory Animal Research Center. Ethics Statement: The
experimental protocol adheres to guidelines for animal use in
research set by the National Institutes of Health and was approved
by the Office of Research, UCSF Institutional Animal Care and
Use Committee (IACUC Approval AN083156-01).
Antigens
AQP4 15-mer and 20-mer peptides were synthesized by
Genemed Synthesis Inc. (San Antonio, TX) according to the
sequences for mouse [17] and human AQP4 proteins [34].
Overlapping 20-mer peptides were offset by ten amino acids.
Peptides corresponding to certain hydrophobic AQP4 sequences
were synthesized in overlapping 15-mer peptide pairs: 41-55 & 46-
60, 121-135 & 126-140, 151-165 & 156-170, 161-175 & 166-180,
191-205 & 196-210, and 221-235 & 226-240. All peptides were
greater than 95% pure by HPLC analysis, and were reconstituted
using 100% sterile DMSO (Sigma-Aldrich, St. Louis, MO) to a
concentration of 20 mg/ml for stock solution. Full length
recombinant (r) human AQP4 (1-323) was expressed in Pichia
pastoris and purified as described [35]. Mouse myelin oligoden-
drocyte glycoprotein (MOG) peptide 35-55 and proteolipid
protein (PLP) 139-151 were synthesized by Auspep (Parkville,
Australia). Following identification of relevant epitopes, indepen-
dent synthesis of candidate peptides was undertaken by Auspep
(Parkville, Australia).
Proliferation Assays
Mice were immunized subcutaneously with 100 mg intact
hrAQP4 or murine AQP4 peptides in CFA. Lymph nodes were
harvested at day 10–12 and 2610
5 cells/well were cultured in 96
well plates in the presence of various concentrations of AQP4, the
same murine peptide, or the corresponding human peptide, for 4
days. Responses to PLP or MOG were used as negative controls.
Data are presented as counts per minute (cpm)
3H-thymidine
incorporated for triplicate wells. Stimulation Index (SI) was
calculated by dividing cpm in wells with Ag by cpm in wells with
no antigen controls of each assay test group.
T cell lines
Mice were immunized subcutaneously with 100 mg hrAQP4 or
murine AQP4 peptides in CFA. Lymph nodes were harvested at
day 10–12, strained through a sterile 70 mM mesh filter. Cells were
washed and plated at a concentration of 5610
6 cells per well in 24
well plates with 25 mg/ml Ag in complete RPMI medium. Lines
were subsequently pushed with antigen at 25 mg/ml and irradiated
syngeneic spleen cells every 14 days, and assayed for proliferative
response to Ag and AQP4 in triplicate.
Cytokine analysis
Supernatants for cytokine analysis were collected at 72 h after
stimulation in culture with Ag as previously described for lymph
node cells. Undiluted supernatants from triplicate culture wells
were assayed for cytokines using ELISA Ready Set Go kits from
eBioscience for both IFN-c and IL-17A using NUNC Maxisorp 96
well ELISA plates. ELISA readouts were visualized with SoftMax
Pro 4.3.1 LS software and Spectramax Plus 384 (Molecular
Devices Corporation, Sunnyvale, CA) and plotted for triplicates
+/2 SEM.
Statistical analysis
Data are presented as mean 6 standard error of mean (SEM)
for triplicates. Stimulation Index (SI) was calculated using the ratio
of means of triplicate experimental conditions to background (no
antigen) controls. Standard errors for experiments using SI refer to
deviations among triplicate conditions over mean background
proliferation. All other statistical analysis was performed using a
one-way multiple-range analysis of variance test (ANOVA) for
multiple comparisons. Two-way ANOVA was performed for
analysis of peptide recall for T-cell line assays taking both peptide
used and concentration of peptide as parameters for analysis.
MHC II epitope prediction by quantitative analytical
programs
Quantitative binding affinity servers were used to predict MHC
II-restricted epitopes of mAQP4 in C57BL/6 (H-2
b) and SJL/J (H-
2
s) mice. Web-based applications used for prediction for murine
alleles included MHCPRED (http://www.darrenflower.info/
mhcpred/) [28,36], NetMHCII (I-A
b only) (http://www.cbs.dtu.
dk/services/NetMHCII/) [29], IEDB (http://tools.immuneepitope.
org/) [27] and MetaMHC (http://www.biokdd.fudan.edu.cn/
Service/MetaMHC.html) [26]. MetaSVMp, an algorithm from
theMetaMHCapplication,isastackedgeneralizationthat combines
the base predictors for SMM-align [30] and local alignment (LA)
kernel [37,38] into a support vector machine. The entire murine
AQP4(M1isoform)sequencewasenteredforanalysisofoverlapping
15 amino acid peptides when applicable. Results are given as values
of IC50 (50% inhibition concentration) from programs available for
quantitative binding prediction, as well as percentile rankings within
algorithms. The inverse of these IC50 values (1/IC50) is plotted in
parallel with the top 20% of predicted binding peptides for
MetaSVMp.
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